LL-37 is your body's natural antibiotic! It's a peptide your immune system makes to kill bacteria, viruses, and fungi. It's especially good at breaking through 'biofilms' - those protective shields that some bacteria build around themselves to hide from antibiotics.
Think of it like: Imagine bacteria have built a fortress wall (biofilm) to protect themselves from your immune system. LL-37 is like a battering ram that smashes through the wall AND attacks the bacteria inside. It's your body's own special forces unit for fighting infections!
Human antimicrobial peptide for immune defense against bacteria, viruses, and biofilms. LL-37 is the only human cathelicidin antimicrobial peptide (AMP) and plays a critical role in innate immunity. It directly kills pathogens and disrupts biofilms that protect chronic infections.
Immune Defense
Immunomodulatory peptides train and strengthen your immune response.
Quickstart Highlights
- Dosage: 50-100mcg
- Frequency: Daily
- Administration: Subcutaneous
- Cycle length: 2-4 weeks as needed
Dosing Plan
| Weeks | Dose | Units |
|---|---|---|
| Acute Infection (Days 1-7) | 100mcg once daily | 4 units (0.04mL) from 2.5mg/mL |
| Standard plan (Weeks 2-4) | 50-100mcg once daily | 2-4 units (0.02-0.04mL) |
| Biofilm plan | 100mcg daily for 2-4 weeks | Target chronic/biofilm infections |
| Maintenance/Prevention | 50mcg 2-3x weekly | 1-2 units per dose |
How to mix
2ml BAC water per 5mg vial
- Draw 2.0mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall - LL-37 is somewhat fragile.
- Gently swirl until completely dissolved (do not shake).
- Label with date. Concentration = 2.5mg/mL (2,500mcg/mL).
- Refrigerate at 2–8°C immediately. Use within 2 weeks.
Syringe Math Reference
- 5mg vial with 2mL BAC water = 2.5 mg/mL = 2,500 mcg/mL
- 50mcg dose = 2 units (0.02mL)
- 75mcg dose = 3 units (0.03mL)
- 100mcg dose = 4 units (0.04mL)
What you'll need
LL-37 Vials (5mg)
- 2 weeks (100mcg/day) 1 vial
- 4 weeks 1-2 vials
- 8 weeks 2-3 vials
Insulin Syringes (U-100)
- 2 weeks 15 syringes
- 4 weeks 30 syringes
- 8 weeks 60 syringes
Bacteriostatic Water (10mL)
- 2 weeks 1 bottle
- 4 weeks 1 bottle
- 8 weeks 1 bottle
Alcohol Swabs
- 2 weeks 1 × 100-count box
- 4 weeks 1 × 100-count box
- 8 weeks 1 × 100-count box
How This Works
LL-37 is a 37-amino acid antimicrobial peptide derived from the C-terminus of human cathelicidin (hCAP18). It works through multiple mechanisms: direct membrane disruption of pathogens (bacteria, viruses, fungi), biofilm disruption allowing antibiotics and immune cells to reach protected bacteria, modulation of inflammatory responses, and promotion of wound healing. It's part of the innate immune system's first-line defense.
Mechanism of Action
How LL-37 Works in Your Body
Peptide Administered
Enters the immune system network
Thymic Activation
Stimulates T-cell maturation in the thymus
Immune Training
Immune cells become more targeted and effective
Defense Strengthened
Better pathogen recognition and response
Benefits & Side Effects
Potential Benefits
- Direct antimicrobial activity against bacteria, viruses, and fungi
- Disrupts biofilms protecting chronic infections
- Supports Lyme disease and co-infection treatment
- Wound healing and tissue repair
- Gut microbiome support and SIBO management
- Enhances innate immune function
Potential Side Effects
- Herxheimer reaction (die-off symptoms) in chronic infection patients
- Injection site irritation
- Temporary flu-like symptoms if pathogen die-off is significant
- Generally well-tolerated at recommended doses
How to store it
- Lyophilized: Store frozen at -20°C for best stability.
- Reconstituted: Refrigerate at 2–8°C; use within 2 weeks.
- LL-37 is more fragile than many peptides - handle carefully.
- Protect from heat and repeated freeze-thaw cycles.
Good to know
- The only human cathelicidin - critical component of innate immunity.
- Directly kills bacteria, viruses, and fungi through membrane disruption.
- Excellent for biofilm disruption - useful in Lyme, SIBO, and chronic infections.
- Synergistic with Thymosin Alpha-1 and BPC-157 for comprehensive immune support.
- May cause Herxheimer reaction in chronic infection patients (die-off symptoms).
- Also supports gut healing and can be used for GI infections.
- Short cycles (2-4 weeks) typically recommended; not for long-term continuous use.
Community Insights
Summarised from 3 sourcesHuman antimicrobial peptide for immune defense against bacteria, viruses, and biofilms. LL-37 is the only human cathelicidin antimicrobial peptide (AMP) and plays a critical role in innate immunity. It directly kills pathogens and disrupts biofilms that protect chronic infections. Useful for chronic
Common Dosages Reported
- 50-100mcg Daily
- Standard protocol dosing
Side Effects Mentioned
- Generally mild, individual variation expected
- See full guide for detailed safety info
Stacking Suggestions
- Consult research and healthcare provider before stacking
What people are saying
Results vary based on individual response
Consistent dosing and timing important
Reviews & Discussion
Real experiences shared by the community — not medical advice.
Significant Symptom Reduction with LL-37
A user reported that using LL-37 led to a dramatic 80-90% decrease in their symptoms. The individual noted feeling significantly better shortly after administration, specifically in the context of managing an illness.
Potential Rosacea Link
A user shared information regarding the potential risks of LL-37, noting that excessive production of this peptide is suspected to be a contributing factor in the development of all subtypes of Rosacea. They provided a reference to clinical literature linking cathelicidin levels to skin inflammation.
Significant symptom reduction via Vitamin D stimulation of LL-37
A user reported that after supplementing with Vitamin D to stimulate cathelicidin production, their symptoms decreased by 80-90%. They noted a significant improvement in their overall physical well-being.
Caution Regarding LL-37 and Rosacea
A user shared research indicating that excessive production of LL-37 is suspected to be a contributing factor in all subtypes of Rosacea. They provided medical literature links to support the caution against using this peptide for those prone to skin inflammation.
No discussion yet — be the first.
No notes yet — be the first.